Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3

Stopped early · Not applicable

Conditions studied: Stroke, Acute, Cerebral Infarction

In brief

This is a study to evaluate the hypothesis that FDA cleared thrombectomy devices plus medical management leads to superior clinical outcomes in acute ischemic stroke patients at 90 days when compared to medical management alone in appropriately selected subjects with the Target mismatch profile and an MCA (M1 segment) or ICA occlusion who can be randomized and have endovascular treatment initiated between 6-16 hours after last seen well.

Key facts

Study ID
NCT02586415
Run by
Gregory W Albers
People needed
182
Starts
2016-04-01
Expected to finish
2017-08-23
Last updated by the study team
2019-05-21

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.